62 related articles for article (PubMed ID: 12115534)
1. Specific immunotherapy against occult cancer metastases.
Lu W; Dong Z; Donawho C; Fidler IJ
Int J Cancer; 2002 Aug; 100(4):480-5. PubMed ID: 12115534
[TBL] [Abstract][Full Text] [Related]
2. Active specific immunotherapy against occult brain metastasis.
Lu W; Su J; Kim LS; Bucana CD; Donawho C; He J; Fidler IJ; Dong Z
Cancer Res; 2003 Mar; 63(6):1345-50. PubMed ID: 12649197
[TBL] [Abstract][Full Text] [Related]
3. Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-beta.
Ozawa S; Lu W; Bucana CD; Kanayama HO; Shinohara H; Fidler IJ; Dong Z
Int J Oncol; 2003 May; 22(5):977-84. PubMed ID: 12684662
[TBL] [Abstract][Full Text] [Related]
4. Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.
Lu W; Fidler IJ; Dong Z
Cancer Res; 1999 Oct; 59(20):5202-8. PubMed ID: 10537298
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.
Zhang F; Lu W; Dong Z
Clin Cancer Res; 2002 Sep; 8(9):2942-51. PubMed ID: 12231540
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
Dong Z; Juang SH; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler IJ
Cancer Immunol Immunother; 1998 May; 46(3):137-46. PubMed ID: 9625537
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T helper cell-independent antitumor response mediated by murine IFN-beta gene delivery in immunocompetent mice.
Brown JL; Barsoum J; Qin XQ
J Interferon Cytokine Res; 2002 Jun; 22(6):719-28. PubMed ID: 12162884
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.
Papa MZ; Mulé JJ; Rosenberg SA
Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517
[TBL] [Abstract][Full Text] [Related]
10. Differential growth of IFN-beta-engineered tumor cells in nude and IFN receptor-null mice.
Zhang F; Lee J; Wang D; Dong Z
J Interferon Cytokine Res; 2006 Feb; 26(2):108-18. PubMed ID: 16487031
[TBL] [Abstract][Full Text] [Related]
11. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
Odaka M; Sterman DH; Wiewrodt R; Zhang Y; Kiefer M; Amin KM; Gao GP; Wilson JM; Barsoum J; Kaiser LR; Albelda SM
Cancer Res; 2001 Aug; 61(16):6201-12. PubMed ID: 11507073
[TBL] [Abstract][Full Text] [Related]
12. Persistence of immunogenic pulmonary metastases in the presence of protective anti-melanoma immunity.
Donawho CK; Pride MW; Kripke ML
Cancer Res; 2001 Jan; 61(1):215-21. PubMed ID: 11196164
[TBL] [Abstract][Full Text] [Related]
13. Metastatic behavior of an adriamycin-resistant murine tumor.
Giavazzi R; Miller L; Hart IR
Cancer Res; 1983 Nov; 43(11):5081-6. PubMed ID: 6616446
[TBL] [Abstract][Full Text] [Related]
14. Suppression of proliferation, tumorigenicity and metastasis of lung cancer cells after their transduction by interferon-beta gene in baculovirus vector.
Lykhova AA; Kudryavets YI; Strokovska LI; Bezdenezhnykh NA; Semesiuk NI; Adamenko IN; Anopriyenko OV; Vorontsova AL
Cytokine; 2015 Feb; 71(2):318-26. PubMed ID: 25497739
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-beta gene: possible role of nitric oxide.
Xie K; Bielenberg D; Huang S; Xu L; Salas T; Juang SH; Dong Z; Fidler IJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2283-94. PubMed ID: 9815626
[TBL] [Abstract][Full Text] [Related]
16. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
18. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
20. Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta.
Park MY; Kim DR; Jung HW; Yoon HI; Lee JH; Lee CT
Cancer Gene Ther; 2010 May; 17(5):356-64. PubMed ID: 19893592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
